Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Rodman David Malcom sold 2,170 Mineralys Therapeutics, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 12, 2026
On Aug 10, 2026, Rodman David Malcom (Chief Medical Officer) sold 2,170 Mineralys Therapeutics, Inc. shares at US$27.09 for US$58,785 under a trading plan, leaving 51,384 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 2,170 shares
- Price
- US$27.09
- Value
- US$58,785
- Holding after
- 51,384 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Option exercise | 2,170 | US$16.00 | 53,554 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 2,170 | US$27.09 | 51,384 | Direct |
Source
Related
- Mineralys Therapeutics, Inc.
- Rodman David Malcom
- Mineralys Therapeutics, Inc. shareholders
- Form 4 · Rodman David Malcom · Jul 20, 2026
- Form 4 · Rodman David Malcom · Jul 15, 2026
- Form 4 · Rodman David Malcom · Jul 10, 2026
- Form 4 · Rodman David Malcom · Jun 17, 2026
- Form 4 · Rodman David Malcom · Jun 12, 2026
- Form 4 · Peterson Kristine · Oct 20, 2026
- Form 4 · Coats Lonnel · Oct 20, 2026
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026